DRUG INEFFECTIVE is the #8 most commonly reported adverse reaction for MEPOLIZUMAB, manufactured by GlaxoSmithKline LLC. There are 4,405 FDA adverse event reports linking MEPOLIZUMAB to DRUG INEFFECTIVE. This represents approximately 2.5% of all 173,706 adverse event reports for this drug.
Patients taking MEPOLIZUMAB who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DRUG INEFFECTIVE4,405 of 173,706 reports
DRUG INEFFECTIVE is a less commonly reported adverse event for MEPOLIZUMAB, but still significant enough to appear in the safety profile.
Other Side Effects of MEPOLIZUMAB
In addition to drug ineffective, the following adverse reactions have been reported for MEPOLIZUMAB:
DRUG INEFFECTIVE has been reported as an adverse event in 4,405 FDA reports for MEPOLIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DRUG INEFFECTIVE with MEPOLIZUMAB?
DRUG INEFFECTIVE accounts for approximately 2.5% of all adverse event reports for MEPOLIZUMAB, making it a notable side effect.
What should I do if I experience DRUG INEFFECTIVE while taking MEPOLIZUMAB?
If you experience drug ineffective while taking MEPOLIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.